MNECX
Price
$20.16
Change
+$0.07 (+0.35%)
Updated
Aug 21 closing price
Net Assets
359.93M
RLEFX
Price
$41.01
Change
+$0.15 (+0.37%)
Updated
Aug 21 closing price
Net Assets
282.59B
Interact to see
Advertisement

MNECX vs RLEFX

MNECX vs RLEFX Comparison Chart in %
View a ticker or compare two or three
VS
MNECX vs. RLEFX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNECX is a Buy and RLEFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 283B vs. MNECX (360M). RLEFX pays higher dividends than MNECX: RLEFX (1.98) vs MNECX (1.21). MNECX was incepted earlier than RLEFX: MNECX (17 years) vs RLEFX (11 years). MNECX (1.80) is less costly to investors than RLEFX (0.39). MNECX is a more actively managed with annual turnover of: 78.00 vs. RLEFX (50.00). RLEFX has a lower initial minimum investment than MNECX: RLEFX (250) vs MNECX (2000). RLEFX annual gain was more profitable for investors over the last year : 12.81 vs. MNECX (0.79). RLEFX return over 5 years is better than : 35.14 vs. MNECX (-7.68).
MNECXRLEFXMNECX / RLEFX
Total Expense Ratio1.800.39462%
Annual Report Gross Expense Ratio1.800.39462%
Fund Existence17 years11 years-
Gain YTD4.82810.21047%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets360M283B0%
Annual Yield % from dividends1.211.9861%
Returns for 1 year0.7912.816%
Returns for 3 years17.3945.8338%
Returns for 5 years-7.6835.14-22%
Returns for 10 years-1.7185.53-2%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIOT0.760.06
+9.01%
Viomi Technology Co Ltd
LYEL15.530.18
+1.17%
Lyell Immunopharma Inc
BPYPP16.430.05
+0.32%
Brookfield Property Partners LP
KYMR119.80-1.70
-1.40%
Kymera Therapeutics
NVCR17.10-0.67
-3.77%
NovoCure Limited